Search research articles
Contact Us
Filters
Showing results (211-220 of 251) with videos related to
Page
of 26
Sort By:
European Urology
|
April 8, 2023
Molecular Urothelial Tumor Cell Subtypes Remain Stable During Metastatic Evolution
Alexander Cox, Niklas Klümper, Johannes Stein, et al.
Cells
|
June 2, 2021
Serum miRNAs Support the Indication for MRI-Ultrasound Fusion-Guided Biopsy of the Prostate in Patients with Low-PI-RADS Lesions
Bastian Keck, Angelika Borkowetz, Julia Poellmann, et al.
Cancers
|
December 23, 2023
Determinants Affecting the Clinical Implementation of a Molecularly Informed Molecular Tumor Board Recommendation: Experience from a Tertiary Cancer Center
Lars Tögel, Christoph Schubart, Sebastian Lettmaier, et al.
Molecular Therapy. Nucleic Acids
|
April 2, 2019
Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer Cells In Vitro and In Vivo
Sven Wach, Madeleine Brandl, Hannes Borchardt, et al.
Histopathology
|
January 10, 2024
Associations of TACSTD2/TROP2 and NECTIN-4/NECTIN-4 with molecular subtypes, PD-L1 expression, and FGFR3 mutational status in two advanced urothelial bladder cancer cohorts
Veronika Bahlinger, Annalena Branz, Pamela L Strissel, et al.
Studies in Health Technology and Informatics
|
August 10, 2012
Designing and implementing a biobanking IT framework for multiple research scenarios
Hans-Ulrich Prokosch, Sebastian Mate, Jan Christoph, et al.
Oncoimmunology
|
October 23, 2023
<i>PD-L1</i> (<i>CD274</i>) promoter hypomethylation predicts immunotherapy response in metastatic urothelial carcinoma
Niklas Klümper, Lennert Wüst, Jonas Saal, et al.
The Journal of Pathology. Clinical Research
|
March 20, 2024
A deep-learning workflow to predict upper tract urothelial carcinoma protein-based subtypes from H&E slides supporting the prioritization of patients for molecular testing
Miriam Angeloni, Thomas van Doeveren, Sebastian Lindner, et al.
Journal for Immunotherapy of Cancer
|
May 26, 2020
Cytotoxic T-cell-related gene expression signature predicts improved survival in muscle-invasive urothelial bladder cancer patients after radical cystectomy and adjuvant chemotherapy
Markus Eckstein, Pamela Strissel, Reiner Strick, et al.
Urology
|
June 21, 2021
Prognostic Role of FGFR Alterations and FGFR mRNA Expression in Metastatic Urothelial Cancer Undergoing Checkpoint Inhibitor Therapy
Karl H Tully, Hendrik Jütte, Ralph M Wirtz, et al.
Page
of 26
Search research articles
Search
Showing results (211-220 of 251) with videos related to
Sort By:
Page
of 26
European Urology
|
April 8, 2023
Molecular Urothelial Tumor Cell Subtypes Remain Stable During Metastatic Evolution
Alexander Cox, Niklas Klümper, Johannes Stein, et al.
Cells
|
June 2, 2021
Serum miRNAs Support the Indication for MRI-Ultrasound Fusion-Guided Biopsy of the Prostate in Patients with Low-PI-RADS Lesions
Bastian Keck, Angelika Borkowetz, Julia Poellmann, et al.
Cancers
|
December 23, 2023
Determinants Affecting the Clinical Implementation of a Molecularly Informed Molecular Tumor Board Recommendation: Experience from a Tertiary Cancer Center
Lars Tögel, Christoph Schubart, Sebastian Lettmaier, et al.
Molecular Therapy. Nucleic Acids
|
April 2, 2019
Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer Cells In Vitro and In Vivo
Sven Wach, Madeleine Brandl, Hannes Borchardt, et al.
Histopathology
|
January 10, 2024
Associations of TACSTD2/TROP2 and NECTIN-4/NECTIN-4 with molecular subtypes, PD-L1 expression, and FGFR3 mutational status in two advanced urothelial bladder cancer cohorts
Veronika Bahlinger, Annalena Branz, Pamela L Strissel, et al.
Studies in Health Technology and Informatics
|
August 10, 2012
Designing and implementing a biobanking IT framework for multiple research scenarios
Hans-Ulrich Prokosch, Sebastian Mate, Jan Christoph, et al.
Oncoimmunology
|
October 23, 2023
<i>PD-L1</i> (<i>CD274</i>) promoter hypomethylation predicts immunotherapy response in metastatic urothelial carcinoma
Niklas Klümper, Lennert Wüst, Jonas Saal, et al.
The Journal of Pathology. Clinical Research
|
March 20, 2024
A deep-learning workflow to predict upper tract urothelial carcinoma protein-based subtypes from H&E slides supporting the prioritization of patients for molecular testing
Miriam Angeloni, Thomas van Doeveren, Sebastian Lindner, et al.
Journal for Immunotherapy of Cancer
|
May 26, 2020
Cytotoxic T-cell-related gene expression signature predicts improved survival in muscle-invasive urothelial bladder cancer patients after radical cystectomy and adjuvant chemotherapy
Markus Eckstein, Pamela Strissel, Reiner Strick, et al.
Urology
|
June 21, 2021
Prognostic Role of FGFR Alterations and FGFR mRNA Expression in Metastatic Urothelial Cancer Undergoing Checkpoint Inhibitor Therapy
Karl H Tully, Hendrik Jütte, Ralph M Wirtz, et al.
Page
of 26